ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 135 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $8,859,000 | -17.6% | 6,238,891 | +1.5% | 0.00% | -50.0% |
Q3 2016 | $10,757,000 | +3.5% | 6,146,647 | +1.1% | 0.00% | 0.0% |
Q2 2016 | $10,395,000 | -13.9% | 6,079,143 | -0.8% | 0.00% | 0.0% |
Q1 2016 | $12,078,000 | +4.4% | 6,130,914 | +0.7% | 0.00% | 0.0% |
Q4 2015 | $11,569,000 | +0.9% | 6,088,954 | +1.4% | 0.00% | 0.0% |
Q3 2015 | $11,469,000 | -59.7% | 6,004,877 | -2.1% | 0.00% | -60.0% |
Q2 2015 | $28,473,000 | +0.6% | 6,136,516 | -5.2% | 0.01% | +25.0% |
Q1 2015 | $28,290,000 | +30.7% | 6,473,674 | +3.8% | 0.00% | +33.3% |
Q4 2014 | $21,646,000 | -14.7% | 6,238,140 | +3.0% | 0.00% | -25.0% |
Q3 2014 | $25,389,000 | -29.1% | 6,059,366 | -0.8% | 0.00% | -33.3% |
Q2 2014 | $35,799,000 | -8.2% | 6,109,109 | -1.3% | 0.01% | -14.3% |
Q1 2014 | $38,987,000 | +10.3% | 6,188,339 | +2.4% | 0.01% | +16.7% |
Q4 2013 | $35,359,000 | +6.4% | 6,044,339 | -4.2% | 0.01% | 0.0% |
Q3 2013 | $33,235,000 | -30.6% | 6,306,373 | +1.4% | 0.01% | -40.0% |
Q2 2013 | $47,888,000 | – | 6,219,156 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 10,500,000 | $17,955,000 | 0.87% |
SENZAR ASSET MANAGEMENT, LLC | 1,872,191 | $3,201,447,000 | 0.70% |
Virtus ETF Advisers LLC | 277,607 | $475,000 | 0.35% |
GLOBEFLEX CAPITAL L P | 571,500 | $977,000 | 0.27% |
Lyons Wealth Management, LLC. | 42,408 | $73,000 | 0.11% |
TFS CAPITAL LLC | 222,736 | $381,000 | 0.07% |
Jacobi Capital Management LLC | 35,000 | $56,000 | 0.03% |
Renaissance Technologies | 5,601,355 | $9,578,000 | 0.02% |
WELLINGTON MANAGEMENT GROUP LLP | 26,725,936 | $45,701,000 | 0.01% |
PRELUDE CAPITAL MANAGEMENT, LLC | 46,300 | $79,000 | 0.01% |